Keywords: Flomax, UK, OTC, Boehringer Ingelheim, USA, Ranbaxy, Generic

UK regulatory agency clears prostate drug Flomax for OTC use; generic competition due next year in USA

Article | 14 December 2009

Print This

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has recently approved of the first over-the-counter (OTC) medicine to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in